When a person is confronted with a possible cancer diagnosis, a biopsy is performed and tissue is taken out. The tissue is tested in a pathology lab and a report is generated. The report confirms or rules out a cancer diagnosis and determines the ‘stages’ or to what extent the cancer has spread. Treatment options are found by information on the size, shape and appearance of the tissue under a microscope. Dako provides the antibodies; reagents and instruments enabling physicians choose the right form of treatment, the first time.
Maria Nunez‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.
|Status:||No. Reviews Published:|
To be seen as an authority on SelectScience, find your products to review today., UT- M.D. ANDERSON CANCER CENTER
Dako Announces Collaboration on Development of PD-L1 Companion Diagnostic Test for Investigational Cancer Drug Opdivo® (nivolumab)
24 Feb 2015
02 Sep 2013
FDA Approves Two Dako Assays as Companion Diagnostics for Genentech’s New Breast Cancer Medicine Kadcyla
06 Mar 2013
15 Jun 2012
22 Feb 2012